Meanwhile, compared with the Model group, 3-MA reduced the expression of Bcl-2 in tumor-bearing mice, but there was no statistical difference (Figure 6H); while 3-MA remarkably increased the expression of Bcl-xl (Figure 6I), which was the same as that of the YFSJ group. The gene discussed is BCL2L1; the disease is neoplasm.